ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,650Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 1448

$985K Total Retail Price of All Prescriptions

Rank: 27 out of 1448

473 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 12,558 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,187 1,138 1 2
SIMVASTATIN 704 650 2 3
METFORMIN HCL 474 440 3 25
DIOVAN 425 412 4 15
OMEPRAZOLE 361 322 5 23
GLIMEPIRIDE 331 307 6 66
ATORVASTATIN CALCIUM 297 276 7 4
LOSARTAN POTASSIUM 271 263 8 11
FUROSEMIDE 257 249 9 7
LISINOPRIL 244 214 10 5
LOVASTATIN 228 214 11 35
CARVEDILOL 209 158 12 1
DONEPEZIL HCL 193 192 13 68
ZOLPIDEM TARTRATE 190 164 14 34
MELOXICAM 188 180 15 73
BENAZEPRIL HCL 185 165 16 26
METOPROLOL TARTRATE 179 160 17 9
BENICAR 179 164 17 50
ISOSORBIDE MONONITRATE ER 179 171 17 16
TAMSULOSIN HCL 167 164 20 46
PLAVIX 165 157 21 14
TRAMADOL HCL 165 142 21 56
ALENDRONATE SODIUM 165 153 21 41
GABAPENTIN 163 132 24 51
HYDROCHLOROTHIAZIDE 157 140 25 18
EXFORGE 154 154 26 80
ALLOPURINOL 153 142 27 43
CLOPIDOGREL 151 145 28 10
CRESTOR 150 144 29 17
JANUVIA 145 145 30 64
ONGLYZA 133 115 31 180
ADVAIR DISKUS 122 118 32 74
PRAVASTATIN SODIUM 121 115 33 20
DIOVAN HCT 118 118 34 29
SPIRIVA 117 115 35 97
AZOR 112 104 36 125
AZITHROMYCIN 112 102 36 76
HYDROCODONE-ACETAMINOPHEN 110 82 S3 38 33
ZETIA 108 108 39 28
AVODART 105 100 40 120
COLCRYS 104 91 41 183
ATENOLOL 101 79 42 12
SINGULAIR 98 90 43 91
LIPITOR 96 89 44 30
NAMENDA 93 93 45 93
FENOFIBRATE 91 79 46 54
METOPROLOL SUCCINATE 85 78 47 6
BYSTOLIC 75 75 48 32
ATELVIA 74 74 49 157
TRILIPIX 71 58 50 86
MECLIZINE HCL 70 68 51 108
LEVOTHYROXINE SODIUM 70 65 51 21
CELEBREX 68 67 53 77
MONTELUKAST SODIUM 63 54 54 135
ACTOS 62 62 55 92
VYTORIN 59 59 56 71
BETAMETHASONE DIPROPIONATE 57 54 57 281
CLONIDINE HCL 56 47 58 45
PEN NEEDLE 55 46 59 173
DEXILANT 53 49 60 87
LANTUS 53 46 60 111
TRIAMCINOLONE ACETONIDE 52 51 62 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.